The alpha2 adrenergic receptor produces cellular responses through activating a guanine nucleotide binding protein (G protein). Very little is known about the initial interactions of agonists with these receptors and the protein conformational changes accompanying those interactions. We are studying the alpha2 adrenergic receptor as a model of agonist-receptor- G protein interactions in membranes. High affinity agonist radioligands permit direct measurements of agonist binding that can be correlated with receptor-mediated responses both in native membranes and in reconstituted systems. We will use rapid mix quench techniques to study the initial binding of [3H] UK 14,304, a full alpha2 agonist, on the 0.3 to 20 second time scale. Parallel rapid kinetic studies of adenylate cyclase inhibition in membranes and G protein activation in reconstituted systems will be carried out under identical conditions. The direct comparison between agonist binding and function will help identify the receptor states associated with G protein activation. In addition to the radioisotopic methods we will develop fluorescence spectroscopic methods to study the G protein conformational changes and subunit interactions induced by the alpha2 adrenergic receptor. For this purpose, G proteins labeled with extrinsic fluorophores will be prepared. Changes in fluorescence intensity will be used for real-time kinetic studies of G protein conformational changes in reconstituted systems. These probes will also be used for studies of fluorescence energy transfer and polarized photobleaching recovery. The latter two methods should provide insights into the validity of the G protein subunit dissociation model in a membrane system. The polarized photobleaching technique which we are developing in reconstituted systems will ultimately be applicable to studies of intact cells. This work will provide new information about the mechanism of alpha2 receptor activation by agonists. More generally, the information on receptor-G protein coupling is applicable to a wide range of biological signalling mechanisms including adenylate cyclase, inositol lipid metabolism and regulation of ion channels.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM039561-04
Application #
3296659
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1988-12-01
Project End
1993-11-30
Budget Start
1991-12-01
Budget End
1992-11-30
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Rorabaugh, Boyd R; Chakravarti, Bandana; Mabe, Nathaniel W et al. (2017) Regulator of G Protein Signaling 6 Protects the Heart from Ischemic Injury. J Pharmacol Exp Ther 360:409-416
Feng, Huijie; Sjögren, Benita; Karaj, Behirda et al. (2017) Movement disorder in GNAO1 encephalopathy associated with gain-of-function mutations. Neurology 89:762-770
Sjögren, Benita; Parra, Sergio; Atkins, Kevin B et al. (2016) Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury. J Pharmacol Exp Ther 357:311-9
Evelyn, Chris R; Lisabeth, Erika M; Wade, Susan M et al. (2016) Small-Molecule Inhibition of Rho/MKL/SRF Transcription in Prostate Cancer Cells: Modulation of Cell Cycle, ER Stress, and Metastasis Gene Networks. Microarrays (Basel) 5:
Blazer, Levi L; Storaska, Andrew J; Jutkiewicz, Emily M et al. (2015) Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors. ACS Chem Neurosci 6:911-9
Parra, Sergio; Huang, Xinyan; Charbeneau, Raelene A et al. (2014) Conditional disruption of interactions between G?i2 and regulator of G protein signaling (RGS) proteins protects the heart from ischemic injury. BMC Pharmacol Toxicol 15:29
Lamberts, Jennifer T; Smith, Chelsea E; Li, Ming-Hua et al. (2013) Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive G?o protein. J Neurosci 33:4369-77
Kaur, Kuljeet; Parra, Sergio; Chen, Rong et al. (2012) G?i2 signaling: friend or foe in cardiac injury and heart failure? Naunyn Schmiedebergs Arch Pharmacol 385:443-53
Waterson, Rachael E; Thompson, Corbin G; Mabe, Nathaniel W et al. (2011) G?(i2)-mediated protection from ischaemic injury is modulated by endogenous RGS proteins in the mouse heart. Cardiovasc Res 91:45-52
Sjogren, Benita; Neubig, Richard R (2010) Thinking outside of the ""RGS box"": new approaches to therapeutic targeting of regulators of G protein signaling. Mol Pharmacol 78:550-7

Showing the most recent 10 out of 29 publications